You could use a calendar app on your phone or a good old-fashioned paper calendarwhatever works for you
Beyond the demonstrated efficacy and benefits of the dual GLP-1/GIP receptor agonist tirzepatide, on the horizon is the question of whether a triple agonist targeting all three receptors (GLP-1/GIP/glucagon) may yield even more efficacious weight loss and glycemic control
FDA-approved options include Wegovy (semaglutide, chronic weight management), Ozempic (semaglutide, type 2 diabetes), Zepbound (tirzepatide, chronic weight management), and Mounjaro (tirzepatide, type 2 diabetes)
J.MailhotD.StewartC
La Vignera S, Condorelli RA, Cannarella R, Duca Y, Calogero AE
Beneficial for uneven skin tone, pigmentation, spots and skin dullness